Elsayed G.E. Elsakka

1.6k total citations
38 papers, 1.3k citations indexed

About

Elsayed G.E. Elsakka is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Elsayed G.E. Elsakka has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Elsayed G.E. Elsakka's work include MicroRNA in disease regulation (24 papers), Circular RNAs in diseases (17 papers) and Cancer-related molecular mechanisms research (13 papers). Elsayed G.E. Elsakka is often cited by papers focused on MicroRNA in disease regulation (24 papers), Circular RNAs in diseases (17 papers) and Cancer-related molecular mechanisms research (13 papers). Elsayed G.E. Elsakka collaborates with scholars based in Egypt, Saudi Arabia and Japan. Elsayed G.E. Elsakka's co-authors include Ahmed S. Doghish, Hesham A. El‐Mahdy, Ahmed Ismail, Ahmed I. Abulsoud, Samy Y. Elkhawaga, Nourhan M. Abdelmaksoud, Ahmed A. El-Husseiny, Maghawry Hegazy, Mahmoud Mohamed Mokhtar and Doaa Fathi and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Experimental Cell Research and Life Sciences.

In The Last Decade

Elsayed G.E. Elsakka

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by Elsayed G.E. Elsakka

Since Specialization

Citations

This map shows the geographic impact of Elsayed G.E. Elsakka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsayed G.E. Elsakka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsayed G.E. Elsakka more than expected).

Fields of papers citing papers by Elsayed G.E. Elsakka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsayed G.E. Elsakka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsayed G.E. Elsakka. The network helps show where Elsayed G.E. Elsakka may publish in the future.

Co-authorship network of co-authors of Elsayed G.E. Elsakka

This figure shows the co-authorship network connecting the top 25 collaborators of Elsayed G.E. Elsakka. A scholar is included among the top collaborators of Elsayed G.E. Elsakka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsayed G.E. Elsakka. Elsayed G.E. Elsakka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease 2025 ·Molecular Neurobiology ·(unknown), (unknown), Ahmed I. Abulsoud, Sherif S. Abdel Mageed, Alaa Ashraf, Elsayed G.E. Elsakka, (unknown), Mouhannad M. Sadek, (unknown), (unknown), Hanan Elimam, Ahmed Hassan Ibrahim Faraag, (unknown), Mohamed A. Ali, Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Ahmed S. Doghish	2
2	The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy 2025 ·Microbial Pathogenesis ·(unknown), Gharieb S. El‐Sayyad, Ahmed I. Abulsoud, Mohamed Hemdan, Ahmed Hassan Ibrahim Faraag, Mohamed A. Ali, Elsayed G.E. Elsakka, Nourhan M. Abdelmaksoud, (unknown), (unknown), Alaa Ashraf, Mohamed Bakr Zaki, Mahmoud A. Elrebehy, (unknown), Mustafa Ahmed Abdel‐Reheim, Sherif S. Abdel Mageed, (unknown), Ahmed S. Doghish	1
3	Agmatine alleviates diabetic-induced hyposalivation in rats: A histological and biochemical study 2024 ·Life Sciences ·(unknown), Lobna A. Saleh, (unknown), Ahmed S. Doghish, Elsayed G.E. Elsakka, (unknown), (unknown), (unknown), M. Adam, (unknown), (unknown), (unknown)	1
4	The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies 2024 ·Experimental Cell Research ·(unknown), Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Shereen Saeid Elshaer, (unknown), Walaa A. El‐Dakroury, Al-Aliaa M. Sallam, Nehal I. Rizk, Mohamed Bakr Zaki, (unknown), Ahmed E. Elesawy, Osama A. Mohammed, Sherif S. Abdel Mageed, (unknown), (unknown), (unknown), Mustafa Ahmed Abdel‐Reheim, Ahmed S. Doghish	1
5	miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma 2023 ·Pathology - Research and Practice ·(unknown), Amr Mohamed Yehia, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, Ahmed Elshafei, Samy Y. Elkhawaga, Ahmed Ismail, Mahmoud Mohamed Mokhtar, Hesham A. El‐Mahdy, Maghawry Hegazy, Mohammed S. Elballal, Osama A. Mohammed, Hussein M. El‐Husseiny, Heba M. Midan, Walaa A. El‐Dakroury, Moataz B. Zewail, Sherif S. Abdel Mageed, Ahmed S. Doghish	25
6	miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay 2023 ·Pathology - Research and Practice ·Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, Nourhan M. Abdelmaksoud, Mohamed Bakr Zaki, Hesham A. El‐Mahdy, Ahmed Ismail, Elsayed G.E. Elsakka, Mai A. Abd‐Elmawla, (unknown), Ahmed S. Doghish	55
7	The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay 2023 ·Pathology - Research and Practice ·Maghawry Hegazy, Mohamed A. Elkady, Amr Mohamed Yehia, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, Ahmed Elshafei, Tamer M. Abdelghany, Samy Y. Elkhawaga, Ahmed Ismail, Mahmoud Mohamed Mokhtar, Hesham A. El‐Mahdy, Ahmed S. Doghish	45
8	A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance 2023 ·Pathology - Research and Practice ·Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, Hesham A. El‐Mahdy, Elsayed G.E. Elsakka, Samy Y. Elkhawaga, Mohamed A. Elkady, Amr Mohamed Yehia, Nourhan M. Abdelmaksoud, Mahmoud Mohamed Mokhtar	49
9	miRNAs as cornerstones in adipogenesis and obesity 2023 ·Life Sciences ·Samy Y. Elkhawaga, Ahmed Ismail, Elsayed G.E. Elsakka, Ahmed S. Doghish, Mohamed A. Elkady, Hesham A. El‐Mahdy	67
10	The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer 2023 ·Pathology - Research and Practice ·Ahmed S. Doghish, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, Hesham A. El‐Mahdy, Elsayed G.E. Elsakka, Sherif S. Abdel Mageed, (unknown), (unknown), Mohammed S. Elballal, Walaa A. El‐Dakroury, (unknown), (unknown), Hussein M. El‐Husseiny, Ahmed I. Abulsoud	40
11	New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations 2023 ·Future Medicinal Chemistry ·Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohammed A. Dahab, Mohamed A. Elkady, Elsayed G.E. Elsakka, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Ibrahim H. Eissa, Ahmed M. Metwaly	24
12	miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance 2023 ·Pathology - Research and Practice ·Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, Sherif S. Abdel Mageed, (unknown), Mohamed Bakr Zaki, Hesham A. El‐Mahdy, Ahmed Ismail, Mai A. Abd‐Elmawla, Hussein M. El‐Husseiny, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Elsayed G.E. Elsakka, Doaa Fathi, Walaa A. El‐Dakroury, Ahmed S. Doghish	34
13	miRNAs orchestration of cardiovascular diseases – Particular emphasis on diagnosis, and progression 2023 ·Pathology - Research and Practice ·Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Hesham A. El‐Mahdy, Ahmed Ismail, Mohammed S. Elballal, Sherif S. Abdel Mageed, Emad Gamil Khidr, Osama A. Mohammed, (unknown), Samy Y. Elkhawaga, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, (unknown), Reem K. Shahin, Heba M. Midan, Mahmoud A. Elrebehy, (unknown), Ahmed S. Doghish, (unknown), (unknown)	30
14	miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses 2023 ·Pathology - Research and Practice ·Hesham A. El‐Mahdy, Ahmed M. Mohamadin, Ahmed I. Abulsoud, Emad Gamil Khidr, Ahmed A. El-Husseiny, Ahmed Ismail, Elsayed G.E. Elsakka, Hamada A. Mokhlis, Hussein M. El‐Husseiny, Ahmed S. Doghish	47
15	miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways 2023 ·Pathology - Research and Practice ·Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Nourhan M. Abdelmaksoud, Mohamed Bakr Zaki, Hesham A. El‐Mahdy, Ahmed Ismail, Doaa Fathi, Elsayed G.E. Elsakka	53
16	miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review 2023 ·Pathology - Research and Practice ·Hesham A. El‐Mahdy, Elsayed G.E. Elsakka, Ahmed A. El-Husseiny, Ahmed Ismail, Amr Mohamed Yehia, Nourhan M. Abdelmaksoud, (unknown), (unknown), Ahmed S. Doghish	57
17	Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats 2023 ·Life Sciences ·Shady Allam, Elsayed G.E. Elsakka, Ahmed Ismail, Ahmed S. Doghish, Amr Mohamed Yehia, (unknown), Hamada A. Mokhlis, (unknown), (unknown), (unknown), (unknown), (unknown), Osama A. Mohammed	38
18	miRNAs as potential game-changers in melanoma: A comprehensive review 2023 ·Pathology - Research and Practice ·Gamil M. Abd‐Allah, Ahmed Ismail, Hesham A. El‐Mahdy, Elsayed G.E. Elsakka, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, (unknown), Samy Y. Elkhawaga, Ahmed S. Doghish	52
19	The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay 2022 ·Pathology - Research and Practice ·Ahmed Ismail, Ahmed I. Abulsoud, Doaa Fathi, Ahmed Elshafei, Hesham A. El‐Mahdy, Elsayed G.E. Elsakka, (unknown), Samy Y. Elkhawaga, Ahmed S. Doghish	55
20	miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers 2022 ·Life Sciences ·Ahmed S. Doghish, Ahmed Ismail, Hesham A. El‐Mahdy, Samy Y. Elkhawaga, Elsayed G.E. Elsakka, Eman A. Mady, Mahmoud A. Elrebehy, Mahmoud A. F. Khalil, Hussein M. El‐Husseiny	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hesham A. El‐Mahdy Breakdown of academic impact, for papers by Xiangming Ding Breakdown of academic impact, for papers by Hao Bo Breakdown of academic impact, for papers by Long Huang Breakdown of academic impact, for papers by Fang Zhou Breakdown of academic impact, for papers by Chengfei Jiang Breakdown of academic impact, for papers by Yan Qin Breakdown of academic impact, for papers by Xiuchong Yu